Now, the biotech has distanced itself from its premerger form by rebranding as Rein Therapeutics. Management said the new name, logo ... that could have a better safety profile than Boehringer ...

Amphista Therapeutics appoints Paul Medeiros as Chief Business OfficerAppointment supports the Company’s ambitions to advance ...

Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition from ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced ...

Detailed price information for Guardant Health Inc (GH-Q) from The Globe and Mail including charting and trades.

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

DUBLIN, IE / ACCESS Newswire / February 6, 2025 / Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, and Innovation Zed, a ...

Robert F. Kennedy Jr. defended his prior public statements on a range of health policy issues in a fiery confirmation ...

We recently published a list of 12 Stocks That Could Split in the Near Future. In this article, we are going to take a look at where Eli Lilly And Co. (NYSE:LLY) stands against other stocks that could ...

A newly discovered line of communication between body muscle and the pituitary gland may play an unexpected role in female ...